ACERNA
AceRNA contributes to regenerative medicine and drug discovery through the discovery of novel miRNA functions. It began operation in April 2018, with its headquarters in Kyoto in Japan.
ACERNA
Industry:
Biopharma Biotechnology Genetics Health Care Life Science
Founded:
2018-04-01
Address:
Kyoto, Kyoto, Japan
Country:
Japan
Website Url:
http://www.acernatec.com
Total Employee:
1+
Status:
Active
Total Funding:
2.57 M USD
Similar Organizations
ACT Genomics
ACT Genomics is a cancer molecular information service company teamed up with experts with multiple yearsโ experience in oncology
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
PlusLife Biotech
PlusLife Biotech is driven to creating newer molecular diagnostic tools using a new generation of genetic technologies.
Toldot Genetics
Toldot Genetics improves healthcare through the use of whole genome sequencing.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Investors List
Hirofumi Miki
Hirofumi Miki investment in Angel Round - AceRNA
Hidetoshi Takano
Hidetoshi Takano investment in Angel Round - AceRNA
SMBC Venture Capital
SMBC Venture Capital investment in Series A - AceRNA
Kyoto University Innovation Capital
Kyoto University Innovation Capital investment in Series A - AceRNA
Kyoto University Innovation Capital
Kyoto University Innovation Capital investment in Seed Round - AceRNA
Official Site Inspections
http://www.acernatec.com
- Host name: server-3-171-76-94.iad89.r.cloudfront.net
- IP address: 3.171.76.94
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109